Atopic Dermatitis Identified as Possible Risk Factor for Headache Disorders, Migraine
Researchers noted that further examination and monitoring for headache disorders in patients with atopic dermatitis may be warranted.
Researchers noted that further examination and monitoring for headache disorders in patients with atopic dermatitis may be warranted.
Dr Alexandra Golant discusses managing multiple conditions in a 17-year-old African American waitress, highlighting the complexities of treating moderate-to-severe atopic dermatitis alongside severe acne and…
VELA is the first phase 3 hidradenitis suppurativa trial to evaluate HiSCR75 as the primary end point.
A recent study highlighted growing concerns within the dermatological community regarding an increase in treatment-resistant fungal strains. Researchers from The University of Texas Health Science…
Bristol Myers Squibb announced 70% of patients maintained significant improvement after 4 years with no new safety concerns.
Supported by an independent educational grant from CymaBay Therapeutics. Patients with primary biliary cholangitis (PBC) experience a disease burden that is often underappreciated. Do you…
Acinonyx Bio’s topical cream, ACX, targets Propionibacterium acnes.
Responding to JAAD Case Reports articles indicating a growing problem
Supported by an independent educational grant from Servier. Join us for an interactive a nd engaging symposium that takes a deep dive into the latest…
Clinicians, especially those who see patients with inflammatory and pigmentary disorders, should incorporate alcohol use disorder screening measures into all patient visits.
We are pleased to invite you to the 2024 Psychiatry Update – a three-day meeting with renowned faculty and informative presentations on bipolar disorder, MDD,…